title: Thrombolytic therapy for acute pulmonary embolism: when do the benefits exceed the risks?
authors.affiliation: Professor, Osteopathic Medical Specialties, Michigan State University College of Osteopathic Medicine, Detroit. Electronic address: steinp@msu.edu.
authors.forename: Paul D
authors.initials: PD
authors.lastname: Stein
authors.affiliation: Dean Emeritus and Professor Emeritus, University of Arizona College of Medicine, Tucson.
authors.forename: James E
authors.initials: JE
authors.lastname: Dalen
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012769:Shock / Q000401:mortality; D015912:Thrombolytic Therapy; D018497:Ventricular Dysfunction, Right / Q000401:mortality
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents